Editas Medicine
Price & Volume
Stats
See more52W Range | $1.12-$11.58 |
Market Cap | $100.7M |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $61.7M |
Revenue Growth (YoY) | -98.9% |
Gross Profit (12 Mos) | -$158.4M |
Diluted EPS | -$2.54 |
News
See moreYahoo Finance • 9 months ago
12 Under-the-Radar Stocks With Massive Upside for 2024
Yahoo Finance • 11 months ago
Top 11 CRISPR Stocks To Invest In
Yahoo Finance • last year
Editas Medicine and Vertex Pharmaceuticals Enter into Non-exclusive License Agreement for Cas9
About
CEO | Dr. Gilmore O'Neill M.D. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 11 Hurley Street, Cambridge, MA, United States, 02141 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 265 |
